Hepatic encephalopathy after treatment with temozolomide

Journal of Neuro-Oncology

Volumn 103, Issue 1, 2011, Pages 163-166

  Goldbecker, Annemarie ^a   Tryc, Anita Blanka ^a   Raab, Peter ^a   Worthmann, Hans ^a   Herrmann, Julian ^a   Weissenborn, Karin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cholestasis; Glioblastoma multiforme; Hepatic encephalopathy; Hepatotoxicity; Temozolomide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLINESTERASE; ETIRACETAM; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MANGANESE; PYRIDOXINE; TEMOZOLOMIDE; THYROTROPIN;

AGED; ANEMIA; APHASIA; ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN HERNIA; BRAIN TOXICITY; CANCER RADIOTHERAPY; CASE REPORT; CAUSAL ATTRIBUTION; CHOLESTASIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; GLIOBLASTOMA; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HYPOKALEMIA; HYPONATREMIA; LIVER BIOPSY; LIVER FATTY DEGENERATION; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; METABOLIC ENCEPHALOPATHY; MULTIMODALITY CANCER THERAPY; PAPILLITIS; PARESIS; POLYNEUROPATHY; TONIC CLONIC SEIZURE; TOXIC HEPATITIS;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HEPATIC ENCEPHALOPATHY; HUMANS; TREATMENT OUTCOME;

EID: 79959936990     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0354-y     Document Type: Article

References (14)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
2. Cohen MH, Johnson JR, Pazdur R (2005) Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 11:6767-6771 (Pubitemid 41428729)
3. Schomerus H, Weissenborn K, Hamster W, Rueckert N, Hecker H (1999) PSE-Syndrom-Test. Psychodiagnostisches Verfahren zur quantitativen Erfassung der (minimalen) hepatischen Enzephalopathie. Swets Test Services, Frankfurt
4. Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB (1999) Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Blood Marrow Transpl 5:306-315
5. Quinio P, Bouche O, Lambolais C, Savry C, Cartier H, Egreteau JP (1997) Fatal hepatic toxicity of DTIC: a new case. Intensive Care Med 23:1099 (Pubitemid 27489928)
6. Herishanu Y, Lishner M, Kitay-Cohen Y (2002) The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazine. Anticancer Drugs 13:177-179 (Pubitemid 34183649)
7. Neyns B, Hoorens A, Stupp R (2008) Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide. Acta Neurol Belg 108:131-134
8. Zakim D, Boyer TD (2003) Hepatology: a textbook of liver disease. Saunders, Philadelphia
9. Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N (2005) Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 62:1385-1390 (Pubitemid 41352055)
10. Skehan S, Norris S, Hegarty J, Owens A, MacErlaine D (1997) Brain MRI changes in chronic liver disease. Eur Radiol 7: 905-909 (Pubitemid 127537110)
11. Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M (2006) The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology 27: 798-806 (Pubitemid 44232986)
12. Lee JW (2000) Manganese intoxication. Arch Neurol 57:597-599
13. Lucchini RG, Martin CJ, Doney BC (2009) From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. Neuromolecular Med 11:311-321
14. Perl DP, Olanow CW (2007) The neuropathology of manganeseinduced Parkinsonism. J Neuropathol Exp Neurol 66:675-682